Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4570-4574

  Scotlandi, Katia ^a   Benini, Stefania ^a   Sarti, Manuela ^a   Serra, Massimo ^a   Lollini, Pier Luigi ^b   Maurici, Daniela ^a   Picci, Piero ^a   Manara, Maria Cristina ^a   Baldini, Nicola ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; DRUG MECHANISM; EWING SARCOMA; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR LOCALIZATION;

ANTIBODIES; BONE NEOPLASMS; CELL MOVEMENT; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; RECEPTOR, IGF TYPE 1; SARCOMA, EWING'S; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029838475     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dehner, L P. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J. Surg. Pathol , 17: 1-13, 1993.
2. Bacci, G., Toni, A., Avella, M , Manfrini, M., Sudanese, A., Ciaroni, D., Boriani, S., Emiliani, E., and Campanacci, M. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer (Phila), 63: 1477-1486, 1989.
3. Horowitz, M. E., Kinsella, T J , Wexler, L. H., Belasco, J., Triche, T , Tsokos, M., Steinberg, S. M., McClure, L., Longo, D. L., Steis, R. G., Glatstein, E , Pizzo, P. A , and Miser, J. S Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J. Clin. Oncol , 11: 1911-1918, 1993.
4. Macaulay, V M. Insulin-like growth factors and cancer. Br. J. Cancer, 65: 311-320, 1992.
5. Rohlik, Q. T , Adams, K., Kull, F. C., and Jacobs, S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res Commun., 149: 276-281, 1987.
6. Delattre, O., Zucman, J., Melot, T., Sastre Garau, X., Zucker, J-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C , Triche, T. J., Aurias, A., and Thomas, G. The Ewing family of tumors: a subgroup of small round cell tumors defined by specific chimeric transcripts. N. Engl J. Med., 331: 294-299, 1994.
7. MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor Hum Pathol., 27: 408-416, 1996.
8. Nakanishi, T., Takahashi, K., Aoki, C., Nishikawa, K., Hattori, T , and Taniguchi, S. Expression of nerve growth factor family neurotrophins in a mouse osteoblastic cell line. Biochem. Biophys. Res. Commun, 198: 891-897, 1994.
9. Yee, D , Favoni, R E., Lebovic, G. S., Lombana, F , Powell, D. R , Reynolds, C. P., and Rosen, N Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. J. Clin. Invest , 86: 1806-1814, 1990
10. Rettig, W. J., Garin-Chesa, P., and Huvos, A. G. Ewing's sarcoma: new approaches to histogenesis and molecular plasticity. Lab. Invest , 66: 133-137, 1992.
11. Sara, V. R., and Hall, K. Insulin-like growth factors and their binding proteins. Physiol. Rev., 70: 591-614, 1990.
12. Baserga, R., and Rubin, R Cell cycle and growth control. Crit Rev. Eukaryotic Gene Expression, 3: 47-61, 1993.
13. Canalis, E., McCarthy, T., and Centrella, M. Growth factors and the regulation of bone remodeling J. Clin. Invest., 81: 277-281, 1988
14. Barres, B. A., Hart, I. K., Coles, H. S. R , Burne, J. F., Voyvodic, J. T , Richardson W. D., and Raff, M C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70: 31-46, 1992.
15. Rotwein, P , Burgess, S. K., Milbrandt, J. D , and Krause, J E Differential expression of insulin-like growth factor genes in rat central nervous system. Proc. Natl. Acad. Sci. USA, 85: 265-269, 1988.
16. van Valen, F., Winkelmann, W., and Jürgens, H Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells. J. Cancer Res. Clin Oncol., 118: 269-275, 1992.
17. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J , 13: 3286-3295, 1994.
18. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res , 55: 249-252, 1995.
19. McKeon, C., Thiele, C J , Ross, R. A , Kwan, M., Triche, T J., Miser, J. S., and Israel, M A Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors Ewing's sarcoma and neuroepithelioma. Cancer Res., 48: 4307-4311, 1988.
20. Shapiro, D. N., Jones, B G., Shapiro, L H , Dias, P , and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin Invest., 94: 1235-1242, 1994
21. Kappel, C C., Velez-Yanguas, M C., Hirschfeld, S., and Hellman, L J. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res., 54. 2803-2807, 1994.
22. cdc2. Cancer Res., 54: 5531-5534, 1994.
23. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H L., Kajstura, J., Rubin R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995